This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lexicon Pharmaceuticals, Inc., Rafael Pharmaceuticals, Inc.. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2020
Title: Lakmal Boteju: Innovator in Pharmaceutical Compounds
Introduction
Lakmal Boteju is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work primarily focuses on novel analogs and derivatives of alkyl fatty acids, which have important therapeutic applications.
Latest Patents
Boteju's latest patents involve pharmaceutical compounds that contain therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, including but not limited to lipoic acid. These formulations are designed for the treatment, prevention, imaging, and diagnosis of various medical disorders. His innovative approach in this area has the potential to enhance medical treatments significantly.
Career Highlights
Throughout his career, Lakmal Boteju has worked with prominent companies in the pharmaceutical industry, including Lexicon Pharmaceuticals, Inc. and Rafael Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
Boteju has collaborated with several professionals in his field, including David John Augeri and Jeffrey Thomas Bagdanoff. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Lakmal Boteju is a distinguished inventor whose work in pharmaceutical compounds is paving the way for new medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile